Related Articles
Correlation between human epidermal growth factor receptor 2 expression level and efficacy of trastuzumab beyond progression in metastatic gastric cancer
Clinical use of trastuzumab combined with different chemotherapy regimens in multi‑line treatment of advanced human epidermal growth factor receptor 2‑positive gastric cancer: A case report
Morphological and biomolecular characteristics of subcentimetric invasive breast carcinomas in Sicily: A multicentre retrospective study in relation to trastuzumab treatment
HER2<sup>+</sup> advanced gastric cancer: Current state and opportunities (Review)
Evaluation of a trastuzumab-containing treatment regimen for patients with unresectable advanced or recurrent gastric cancer